172 related articles for article (PubMed ID: 29033672)
1. Role of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in the Evaluation of Head and Neck Carcinoma.
Abouzied MM; Fathala A; Alsugair A; Muhaideb AIA; Qahtani MHA
World J Nucl Med; 2017; 16(4):257-265. PubMed ID: 29033672
[TBL] [Abstract][Full Text] [Related]
2. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
3. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
Kitajima K; Suenaga Y; Sugimura K
Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
[TBL] [Abstract][Full Text] [Related]
4. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Hannah A; Scott AM; Tochon-Danguy H; Chan JG; Akhurst T; Berlangieri S; Price D; Smith GJ; Schelleman T; McKay WJ; Sizeland A
Ann Surg; 2002 Aug; 236(2):208-17. PubMed ID: 12170026
[TBL] [Abstract][Full Text] [Related]
6. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
Kitajima K; Miyoshi Y
Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
[TBL] [Abstract][Full Text] [Related]
9. Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
Escott EJ
Radiol Clin North Am; 2013 Sep; 51(5):881-93. PubMed ID: 24010911
[TBL] [Abstract][Full Text] [Related]
10. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
[TBL] [Abstract][Full Text] [Related]
11. Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors.
Zanation AM; Sutton DK; Couch ME; Weissler MC; Shockley WW; Shores CG
Laryngoscope; 2005 Jul; 115(7):1186-90. PubMed ID: 15995504
[TBL] [Abstract][Full Text] [Related]
12. [PET-CT in head and neck cancer].
Send T; Kreppel B; Gaertner FC; Bundschuh RA; Strunk H; Bootz F; Essler M
HNO; 2017 Jun; 65(6):504-513. PubMed ID: 28451717
[TBL] [Abstract][Full Text] [Related]
13. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
14. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
15. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
17. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of
Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
[TBL] [Abstract][Full Text] [Related]
19. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of simultaneous whole-body
Chan SC; Yeh CH; Yen TC; Ng SH; Chang JT; Lin CY; Yen-Ming T; Fan KH; Huang BS; Hsu CL; Chang KP; Wang HM; Liao CT
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1297-1308. PubMed ID: 29502310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
